scholarly article | Q13442814 |
P356 | DOI | 10.1006/CLIN.1993.1059 |
P698 | PubMed publication ID | 8519091 |
P50 | author | Ricard Cervera i Segura | Q53547424 |
Graham R. V. Hughes | Q73300356 | ||
Munther A. Khamashta | Q73418907 | ||
P2093 | author name string | D P D'Cruz | |
A Gürler | |||
G Tokgöz | |||
L S Atmaca | |||
N Düzgün | |||
A O Aydìntug | |||
P433 | issue | 2 | |
P921 | main subject | Behçet's disease | Q911427 |
P304 | page(s) | 157-162 | |
P577 | publication date | 1993-05-01 | |
P1433 | published in | Clinical Immunology and Immunopathology | Q23929985 |
P1476 | title | Antibodies to endothelial cells in patients with Behçet's disease | |
P478 | volume | 67 |
Q35035563 | Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease |
Q36735088 | Anti-Neutrophil Cytoplasmic Antibody in Behçet's Disease |
Q84569843 | Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease |
Q72220659 | Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease |
Q33566285 | Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity. |
Q41519637 | Antiendothelial cell antibodies (AECA) in patients with uveoretinitis |
Q42445317 | Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases |
Q38275100 | Behçet syndrome: from pathogenesis to novel therapies |
Q33790079 | Behçet's disease: an enigmatic vasculitis |
Q71731379 | Bilateral central retinal vein thrombosis in Behçet's disease |
Q87248193 | Cytokines, adhesion molecules, antiendothelial cell autoantibodies and vascular disease |
Q84983011 | Detection of specific markers : our research on the marker in patients with Kawasaki disease |
Q35542134 | Electron Transfer Flavoprotein Subunit Beta Is a Candidate Endothelial Cell Autoantigen in Behçet's Disease |
Q71541327 | Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease |
Q44461414 | Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease |
Q36870010 | HnRNP A1 is Involved in Deep Vein Thrombosis Patients with Behçet's Disease |
Q34113309 | Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet's disease |
Q34591368 | Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells |
Q34460045 | Immunopathology of the noninfectious posterior and intermediate uveitides |
Q38521360 | Left ventricular intracardiac thrombus in a patient with Behçet disease successfully treated with immunosuppressive agents without anticoagulation: a case report and review of the literature |
Q41914471 | Levels of soluble Fas/APO-1 in patients with Behçet's disease |
Q40603553 | Mechanisms of epithelial damage: are there parallels between bullous skin diseases and asthma? |
Q36666808 | Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. |
Q34604578 | Pathological haemostasis and "prothrombotic state" in Behçet's disease. |
Q39677913 | Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. |
Q61054143 | Soluble intercellular adhesion molecule-l (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis |
Q41631341 | Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies |
Q51631639 | Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behçet's disease. |
Search more.